Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed versus flexible cetrorelix antagonist protocol in IVF for women with PCOS
IRCT20091018002604N6Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Oct 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cetrorelix and recombinant human follicle stimulating hormone in infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Number of M2 oocytes. Started Oct 2023; status: completed.
02
Drugs
cetrorelixrecombinant human follicle stimulating hormone
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20091018002604N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091018002604N6.